The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
L. Kadasi, T. Koller
Bratislavské lekárske listy, 2013
View PDFchevron_right
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
Rebecca Roberts, Richard Gearry, Murray Barclay
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Thiopurine S -methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients
D. Vlachodimitropoulos, Ioanna Panayotou
Journal of Clinical Pharmacy and Therapeutics, 2010
View PDFchevron_right
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations
Johanna Escher
Digestive and Liver Disease, 2005
View PDFchevron_right
On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance
Ad van Bodegraven
Current Drug Metabolism, 2009
View PDFchevron_right
Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Son Duong
PloS one, 2015
View PDFchevron_right
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
Sven Almer
Gut, 2006
View PDFchevron_right
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease
Andre Van Rij
Inflammatory bowel diseases, 2018
View PDFchevron_right
Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
Aldis Pukitis
Therapeutic Advances in Gastroenterology
View PDFchevron_right
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece
Elias Kouroumalis
European Journal of Gastroenterology & Hepatology, 2017
View PDFchevron_right
Thiopurine S-Methyltransferase Gene Polymorphisms in a Healthy Slovak Population and Pediatric Patients with Inflammatory Bowel Disease
Alica Chocholova
Nucleosides, Nucleotides and Nucleic Acids, 2013
View PDFchevron_right
Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy
Salvatore Cucchiara
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
Prateek Bhatia
2021
View PDFchevron_right
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients
Renata Fróes
World journal of gastroenterology : WJG, 2014
View PDFchevron_right
Thiopurines in inflammatory bowel disease: New strategies for optimization of pharmacotherapy?
Anthony Lopez
Current Gastroenterology Reports, 2006
View PDFchevron_right
A Practical Non-Extraction Direct Liquid Chromatography Method for Determination of Thiopurine S-Methyltransferase Activity in Inflammatory Bowel Disease
Amir Kiani
Acta medica Iranica, 2017
View PDFchevron_right
Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine
Simon Campbell
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease
Loredana Serpe
Alimentary Pharmacology & Therapeutics, 2009
View PDFchevron_right
Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease
Themos Dassopoulos
Clinical Gastroenterology and Hepatology, 2004
View PDFchevron_right
Biomarker-based thiopurine therapy for inflammatory bowel disease
Momir Mikov
Macedonian Pharmaceutical Bulletin
View PDFchevron_right
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
Richard Gearry
Journal of Gastroenterology and Hepatology, 2005
View PDFchevron_right
Allelic variants of the thiopurine s-methyltranferase deficiency in patients with ulcerative colitis and in healthy controls
Cesar Diaz
The American Journal of Gastroenterology, 2000
View PDFchevron_right
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
Paul Seed
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Pharmacogenetics of thiopurines: can posology be guided by laboratory data?
Tullio Giraldi
Radiol, 2004
View PDFchevron_right
Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients
Luis Rodrigo
The American journal of gastroenterology, 2006
View PDFchevron_right